Find Academic Supervisors

Martin Schlumberger is a leading oncologist and Professor of Clinical Medicine at Université Paris-Saclay, with a 40-year career dedicated to thyroid cancer research and treatment. He is affiliated with Gustave Roussy, where he has integrated clinical practice and research, and contributed to establishing multidisciplinary thyroid cancer centers in Italy as an Associate Professor at Sapienza University in Rome. Key roles: Oncologist at Gustave Roussy, Professor at Université Paris-Saclay, Associate Professor at Sapienza University in Rome Research focus: Genomic signatures in thyroid cancer, tyrosine kinase inhibitors, radiobiology, medical-economic analyses, and patient quality-of-life assessments Scientific Contributions: Developed the first thyroglobulin trial in Europe during his thesis Advanced genomic differentiation between radiation-induced and spontaneous thyroid cancers through collaborations with CEA-INSTN Championed active monitoring for small thyroid tumors, reducing aggressive treatments Co-developed tyrosine kinase inhibitors combined with immunotherapy for advanced thyroid cancers Awards & Recognition: Academy of Medicine award (France) Academy of Science award (France) WHO reference center designation for thyroid radiobiology in 1997 National Expert Centre for Refractory Thyroid Cancers in 2009 Leadership & Teaching: Founded the Gustave Roussy School of Cancer Sciences Chaired the EORTC Endocrine Tumour Group Directed Université Paris-Saclay's Doctoral School of Oncology Co-authored over 350 original articles and two books

• Oncology
• Thyroid Cancer
• Genomic Research
• +6 more

Prof. Dr. Pascale Fanen is a senior academic and researcher specializing in genetics and respiratory diseases, with a focus on rare monogenic disorders and surfactant-related lung conditions. Her collaborative research spans molecular pharmacology, pediatric pulmonology, and genetic mechanisms of lung disease. Her research interests include ABC transporters , surfactant protein disorders , idiopathic pulmonary fibrosis , and genetic variants in lung carcinogenesis . She investigates how monogenic mutations contribute to isolated and systemic respiratory phenotypes, particularly in pediatric and rare disease contexts. The recent publications highlight a strong trend in identifying genetic underpinnings of rare lung diseases, integrating molecular biology with clinical phenotyping. Her work frequently involves international collaboration and contributes to the understanding of disease mechanisms in Cystic Fibrosis , interstitial lung disease , and hereditary cancer risk . While no specific awards are listed in the provided text, her publication record in high-impact journals such as Biochemical Pharmacology and European Respiratory Journal reflects significant scientific contributions. She actively collaborates with laboratory heads and clinical researchers, suggesting a leadership role in research teams focused on genetic lung disorders. Pascale Fanen advises or mentors students in genetics and respiratory medicine, though specific names are not provided. She is involved in multi-center research networks such as the OrphaLung network, indicating active participation in collaborative grants and rare disease research initiatives. Her work likely involves funding from national or European rare disease research programs. She is affiliated with research teams investigating monogenic respiratory diseases, possibly within a university medical or life sciences faculty. Her collaborations suggest integration in labs focused on molecular genetics, pediatric pulmonology, and translational respiratory research.

• Respiratory Diseases
• Genetics
• Rare Monogenic Diseases
• +5 more

Laurent Brunaud is a Professor at the University of Nancy, affiliated with the Brabois University Hospital. His primary research focuses on metabolic, endocrine, and obesity surgery, with significant contributions to understanding surgical outcomes and developing diagnostic tools using advanced technologies like mid-infrared spectroscopy and machine learning. Primary Affiliation: Brabois University Hospital, University of Nancy Academic Rank: Professor His research spans multiple subfields including hyperparathyroidism , pancreatic surgery , adrenal oncology , and bariatric surgical outcomes . Recent publications highlight his work in creating surgical ontologies and improving diagnostic accuracy for metabolic disorders. Collaborations include work with the French Society of Endocrinology, AFCE, and EUROCRINE® registry. He currently co-supervises a thesis with Dr. Claire Nomine-Criqui.

• Endocrine Surgery
• Metabolic Surgery
• Bariatric Surgery
• +7 more

Abderrahim Oussalah is a Professor and MD at the University of Lorraine, Faculty of Medicine, based at Campus Brabois Santé in Vandoeuvre-lès-Nancy. His research focuses on inborn errors of metabolism, particularly cobalamin (vitamin B12) metabolism, epigenetics, and biomarker discovery for liver/kidney disorders and genetic diseases. His research interests center on inborn errors of metabolism with emphasis on cobalamin metabolism disorders (cblC, cblG), epigenetic mechanisms in diseases like hepatocellular carcinoma, and biomarker development for conditions including cirrhosis, sepsis, and inflammatory bowel disease. His work integrates multi-omics approaches to correlate molecular findings with clinical phenotypes. Recent publications reveal strong trends in genetic diagnostics (exome sequencing for Mendelian disorders), epigenetic signatures (DNA methylation for cancer detection), and clinical biomarker validation (pro-adrenomedullin for bacterial peritonitis, calprotectin for ulcerative colitis). His research bridges basic science with clinical applications, particularly in rare metabolic diseases. Scientific contributions include: Discovery of epi-cblC disorder (transgenerational epimutation) Development of epigenomic signatures for hepatocellular carcinoma Validation of novel biomarkers for sepsis and renal dysfunction in cirrhosis Expansion of genetic spectrum for Tatton-Brown-Rahman syndrome His collaborative work involves multi-institutional studies on vitamin B12 metabolism, with technical platforms including functional genomics, bioinformatics, and specialized cell culture. Current projects focus on epigenome-wide alterations in metabolic disorders and translation of biomarkers to clinical practice.

• Inborn Errors of Metabolism
• Cobalamin (Vitamin B12) Metabolism
• Epigenetics
• +5 more